Pseudoprogression as an adverse event of glioblastoma therapy-Reference-Cited by-同舟云学术

Pseudoprogression as an adverse event of glioblastoma therapy

Published:2017-11-03 Issue:12 Volume:6 Page:2858-2866
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Balaña Carmen¹^ORCID,Capellades Jaume²,Pineda Estela³,Estival Anna¹,Puig Josep⁴,Domenech Sira⁵,Verger Eugenia⁶,Pujol Teresa⁷,Martinez-García Maria⁸,Oleaga Laura⁷,Velarde JoseMaria⁹,Mesia Carlos¹⁰,Fuentes Rafael¹¹,Marruecos Jordi¹¹,Del Barco Sonia¹²,Villà Salvador¹³,Carrato Cristina¹⁴,Gallego Oscar¹⁵,Gil-Gil Miguel¹⁰,Craven-Bartle Jordi¹⁶,Alameda Francesc¹⁷,

Affiliation:

1. Medical Oncology; Institut Catala Oncologia (ICO); Badalona Barcelona Spain

2. Radiology; Hospital del Mar; Barcelona Spain

3. Medical Oncology; Hospital Clinic; Barcelona Spain

4. Imaging Research Unit; Institut de Diagnostic per la Imatge (IDI); Biomedical Research Institute (IDIBGI); Hospital Universitari Dr Josep Trueta; Girona Spain

5. Radiology; Institut Diagnòstic per la Imatge (IDI); Badalona Barcelona Spain

6. Radiation Oncology; Hospital Clinic; Barcelona Spain

7. Radiology; Hospital Clinic; Barcelona Spain

8. Medical Oncology; Hospital del Mar; Barcelona Spain

9. Statistics; Institut Catala Oncologia (ICO); Badalona Barcelona Spain

10. Medical Oncology; IDIBELL; Institut Catala Oncologia (ICO); Hospitalet de LLobregat; Barcelona Spain

11. Radiation Oncology; Institut Catala Oncologia (ICO); Girona Spain

12. Medical Oncology; Institut Catala Oncologia (ICO); Girona Spain

13. Radiation Oncology, Statistics; Institut Catala Oncologia (ICO); Badalona Barcelona Spain

14. Pathology; Hospital Germans Trias I Pujol; Badalona Barcelona Spain

15. Medical Oncology; Hospital de Sant Pau; Barcelona Spain

16. Radiation Oncology; Hospital de Sant Pau; Barcelona Spain